On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19.
Saved in:
| Title: | On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19. |
|---|---|
| Authors: | Miki S; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan., Sasaki H; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan., Horiuchi H; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan., Miyata N; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan., Yoshimura Y; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan., Miyazaki K; Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan., Matsumura T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Takahashi Y; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan., Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan., Matano T; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.; Department of AIDS Vaccine Development, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Kawana-Tachikawa A; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.; Department of AIDS Vaccine Development, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Tachikawa N; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan. |
| Source: | PloS one [PLoS One] 2021 Jul 13; Vol. 16 (7), pp. e0254640. Date of Electronic Publication: 2021 Jul 13 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34255796 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Miki+S%22">Miki S</searchLink>; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sasaki+H%22">Sasaki H</searchLink>; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Horiuchi+H%22">Horiuchi H</searchLink>; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Miyata+N%22">Miyata N</searchLink>; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimura+Y%22">Yoshimura Y</searchLink>; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Miyazaki+K%22">Miyazaki K</searchLink>; Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Matsumura+T%22">Matsumura T</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+Y%22">Takahashi Y</searchLink>; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+T%22">Suzuki T</searchLink>; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Matano+T%22">Matano T</searchLink>; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.; Department of AIDS Vaccine Development, Institute of Medical Science, University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kawana-Tachikawa+A%22">Kawana-Tachikawa A</searchLink>; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.; Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.; Department of AIDS Vaccine Development, Institute of Medical Science, University of Tokyo, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tachikawa+N%22">Tachikawa N</searchLink>; Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2021 Jul 13; Vol. 16 (7), pp. e0254640. <i>Date of Electronic Publication: </i>2021 Jul 13 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34255796 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0254640 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0254640 Titles: – TitleFull: On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Miki S – PersonEntity: Name: NameFull: Sasaki H – PersonEntity: Name: NameFull: Horiuchi H – PersonEntity: Name: NameFull: Miyata N – PersonEntity: Name: NameFull: Yoshimura Y – PersonEntity: Name: NameFull: Miyazaki K – PersonEntity: Name: NameFull: Matsumura T – PersonEntity: Name: NameFull: Takahashi Y – PersonEntity: Name: NameFull: Suzuki T – PersonEntity: Name: NameFull: Matano T – PersonEntity: Name: NameFull: Kawana-Tachikawa A – PersonEntity: Name: NameFull: Tachikawa N IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 07 Text: 2021 Jul 13 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 16 – Type: issue Value: 7 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |